Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v2-FR
Language French French
Date Updated 2021-09-03 2021-09-03
Drug Identification Number 02238617 02238617
Brand name VIRACEPT -250MG VIRACEPT -250MG
Common or Proper name VIRACEPT VIRACEPT
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients NELFINAVIR NELFINAVIR
Strength(s) 250MG 250MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 300 BOTTLE COUNT 300 BOTTLE COUNT
ATC code J05AE J05AE
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2022-05-31 2022-05-31
Actual discontinuation date
Remaining supply date 2022-05-31 2022-05-31
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Discontinued for commercial reasons. Distributed by ViiV Healthcare. Discontinued for commercial reasons. Distributed by ViiV Healthcare.
Health Canada comments